The global menopause supplement market, now worth approximately £13 billion and projected to reach £18.5 billion by 2030, is under scrutiny for preying on midlife women's anxieties with products that lack scientific evidence and may pose health risks. This booming industry largely emerged after a 2002 study, the Women's Health Initiative (WHI), which linked hormone replacement therapy (HRT) to an increased risk of breast cancer.
The Aftermath of the WHI Study
Although the WHI study's headline finding of a 26% increase in invasive breast cancer was later found to be based on a flawed interpretation of relative risk—an actual increase of less than 0.5% over five years—it triggered widespread panic. Many women shied away from HRT, turning instead to supplements. Sales of ingredients like black cohosh surged, and the market for menopause-specific wellness products expanded significantly.
Questionable Ingredients and Dosing
An examination of 201 menopause supplements by Poppy Sullivan, a medical student at University College London, revealed a lack of common ingredients, suggesting that even manufacturers may not know which components are effective. The most frequent vitamin found was B6, often at doses thousands of percent above the recommended daily allowance, with high intake linked to nerve damage. Other supplements contained high levels of zinc, potentially leading to urinary tract infections, or vitamin D and B12 at vastly different and sometimes excessive dosages. Red clover, a phytoestrogen, appeared in less than half of the tested products. The study found no evidence to support the use of most ingredients for menopause symptoms, with only vitamin D and calcium being occasionally recommended by some menopause societies. Black cohosh, present in 8% of supplements, has been implicated in liver injuries, and some products exceeded recommended zinc limits.
The Role of Influencer Marketing
The supplement industry is closely intertwined with social media influencers. The global supplement market is worth over $200 billion, with influencer marketing generating billions annually. Many products are marketed as AI-recommended, but former marketers reveal these quizzes are merely data-gathering tools leading to predetermined supplement suggestions. Some companies, operating as holding companies for various supplements, have outsourced content creation to platforms that hire individuals for low pay to film generic clips. These clips are then edited by low-cost operations in countries like El Salvador and the Philippines, often with disclaimers like "paid presenters, simulated results" in minuscule font. This content is A/B tested, with extreme or emotionally charged testimonials frequently performing best. This data-driven approach, focused on performance marketing, prioritizes sales over scientific validation. "It's a data business, not a health business," one former marketer stated, emphasizing that supplements are chosen for their high profit margins, not necessarily their efficacy.
Misinterpreted Risks and Missed Opportunities
The initial panic surrounding HRT was exacerbated by misinterpretations of the WHI study. The 26% figure, representing a relative increase, overshadowed the fact that the absolute risk of breast cancer was very small. Furthermore, the study's participants were older, on average, than the typical HRT user, meaning the risks and benefits for younger women starting HRT around the onset of menopause were misrepresented. For women starting HRT in their early fifties, the benefits, such as reduced risk of heart disease and death, may outweigh the harms. Conversely, estrogen-only HRT in women who had undergone hysterectomies was found to be associated with a decreased risk of breast cancer, a finding that received little attention compared to the initial negative headlines. Experts suggest that tens of thousands of American women may have died prematurely by avoiding estrogen therapy due to these widespread, albeit misinterpreted, concerns.
The British Menopause Society noted that this decline in HRT prescribing has deprived a generation of women of an improved quality of life during their menopausal years. The wellness industry, meanwhile, continues to profit from these fears, promoting products with "fake science" and playing on consumer anxieties for financial gain, rather than focusing on genuine health optimization.